Martis Capital Invests in DCN Dx
November 19, 2020
Martis Capital has made a growth equity investment in DCN Dx, a Carlsbad, California-based lateral flow diagnostics developer and contract developer of rapid point-of-care tests. As part of the transaction, Charlie Mamrak will join DCN Dx as CEO; the capital will be used to accelerate growth and expand the company's diagnostic capabilities. Financial terms were not disclosed and Pegasus Capital and TM Capital advised on the deal.
- Buyers
- Martis Capital
- Targets
- DCN Dx
- Industry
- Medical Devices
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
DCN Dx Acquires PortaScience
June 17, 2021
Medical Devices
DCN Dx, a Carlsbad, California-based developer of point-of-care diagnostics, has completed the acquisition of PortaScience, Inc., a dry-chemistry focused point-of-care diagnostics development company based in Moorestown, New Jersey. The deal adds PortaScience's PortaCheck animal-health product line and expands DCN Dx's assay development, engineering, and product portfolio for healthcare, veterinary, and consumer diagnostics.
-
DCN Dx Acquires Biomed Diagnostics
April 25, 2022
Medical Devices
DCN Dx has completed its acquisition of Biomed Diagnostics, Inc., a microbiological testing products company based in White City, Oregon. The deal expands DCN Dx's point-of-use testing and sampling capabilities across human, veterinary, food safety and environmental markets by adding Biomed's InPouch/InTray culture and transport product lines.
-
Ampersand Capital Partners Completes Growth Equity Investment in GenDx
May 8, 2019
Biotechnology
Ampersand Capital Partners completed a minority growth equity investment in Genome Diagnostics B.V. (GenDx), a Utrecht-based provider of molecular diagnostic kits and analysis software for transplantation and companion diagnostics. The partnership will support GenDx's organic growth and M&A strategy; Ampersand's David Parker and Operating Partner Mike Evans joined GenDx's board.
-
Martis Capital and Din Ventures Invest in Archway Dental Partners
January 19, 2024
Dental
Martis Capital and Din Ventures announced a growth investment in Archway Dental Partners, a Danbury, Connecticut-based dental partnership supporting 70 dentists across 23 locations. The capital will support Archway Dental's expansion as it aims to become a leading multi-specialty dental provider across New England and the Northeast.
-
NMS Capital Recapitalizes DCM Services
February 25, 2020
Data & Analytics
NMS Capital has partnered with DCM Services' management in a recapitalization of DCM Services, a Minneapolis-area provider of data and contact management solutions for estate and specialty receivables recovery. The investment will support growth and scaling of DCM's proprietary Probate Finder technology, expand capabilities, and target growth across financial services, healthcare and other end markets.
-
Martis Capital Invests in Alcanza Clinical Research
October 3, 2022
Healthcare Services
Martis Capital, a middle‑market healthcare private equity firm, announced an investment in Alcanza Clinical Research, a clinical research site network platform founded in December 2021. Martis will support Alcanza's national expansion and capability build‑out — Alcanza has already consolidated five clinical research sites across multiple states and will pursue additional acquisitions and strategic partnerships to scale Phase I–IV capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.